Brookings Report Examines Private Sector Investments In Health R&D Dedicated To Developing Countries
Brookings Institution’s “TechTank”: Less than four percent of private investment in health R&D targets the developing world
Liz Sablich, director of communications for governance studies at Brookings, discusses findings from a report on private sector investments in overall health R&D, which found “an exceedingly small share was dedicated to the developing world,” and highlights recommendations to improve private investment in global health drugs and vaccines (4/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.